Synbias Pharma AG

Synbias Pharma AG is umbrella of Synbias-Gemini Group, headquartered in Schaffhausen, Switzerland, which 100% shareholder of Gemini PharmChem Mannheim GmbH. Synbias Pharma AG is the heart of business development and sales operations. Synbias Pharma AG dedicated team is responsible for driving growth, forging strategic partnerships, and expanding market reach. By leveraging deep industry knowledge and customer insights, we ensure that our high-quality Active Pharmaceutical Ingredients (APIs) reach clients across 5 continents. The Switzerland office is pivotal in aligning our business objectives with customer needs, ensuring that we remain a trusted partner in the pharmaceutical industry. Gemini PharmChem Mannheim GmbH is the production facilities, a highly esteemed manufacturing and R&D site located in Mannheim, Germany. As the leading global API supplier of anthracycline antibiotics, we hold a 30-50% share of the world market. Annually, approximately 200 kilograms of our APIs, in quantities ranging from 100 grams to 15 kilograms, are shipped to customers in 21 countries across 5 continents. Our Quality System is meticulously designed to meet the stringent requirements of Swissmedic, cGMP, FDA, and our customers. Gemini PharmChem Mannheim GmbH is recognized by our business partners as a competent, reliable, and efficient company, characterized by our innovative spirit and customized approach to service. Our leading position in niche markets is built on the expertise, dedication, and loyalty of our employees. We are capable of developing manufacturing processes for New Chemical Entities and supplying APIs for all phases of a drug’s life cycle, from initial clinical studies to commercial supply.